Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis
The British Journal of Psychiatry · 2026-04 · 228 (4) · 317-323
DOI: 10.1192/bjp.2025.72 ↗Kurz gefasst
Fachartikel in der Zeitschrift The British Journal of Psychiatry, online erschienen am 06.05.2025. Verfasst von Antti Mustonen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: Antipsychotic Agents, Secondary Prevention, Psychoses, Substance-Induced. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cannabis use is linked to treatment non-adherence and relapses in psychotic disorders. Antipsychotic medication is effective for relapse prevention in primary psychoses, but its effectiveness after cannabis-induced psychosis (CIP) remains unclear.
Aims
To examine the effectiveness of antipsychotic medication for relapse prevention following the first clinically diagnosed CIP.
Method
A cohort of 1772 patients (84.1% men) with incident CIP was identified from the Swedish National Patient and Micro Data for Analyses of Social Insurance registers. The primary outcome was hospitalisation due to any psychotic episode. Drug use data were collected from the Prescribed Drug Register and modelled into drug use periods using the PRE2DUP method. A within-individual Cox regression model was used to study the risk of outcomes during the use of different oral or long-acting injectable (LAI) antipsychotics compared with non-use.
Results
The mean age at first diagnosis was 26.6 years (s.d. = 8.3). Of the cohort, 1343 (75.8%) used antipsychotics and 914 (51.3%) experienced psychosis hospitalisation during the follow-up. Any antipsychotic use was associated with a decreased risk of psychosis hospitalisation (adjusted hazard ratio (aHR) 0.75; 95% CI 0.67–0.84). Specific antipsychotics associated with decreased risk included aripiprazole LAI (aHR 0.27; 95% CI 0.14–0.51), olanzapine LAI (aHR 0.28; 95% CI 0.15–0.53), clozapine (aHR 0.55; 95% CI 0.34–0.90), oral aripiprazole (aHR 0.64; 95% CI 0.45–0.91), antipsychotic polytherapy (aHR 0.74; 95% CI 0.63–0.87) and oral olanzapine (aHR 0.81; 95% CI 0.69–0.94).
Conclusions
In particular, LAIs, clozapine and oral aripiprazole were associated with a decreased risk of psychosis relapse following CIP. Prescribers should consider using more LAIs for better treatment outcomes after CIP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
- Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
- Department of Psychiatry, Seinäjoki Central Hospital, Seinäjoki, Finland.
- Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Kuopio, Finland.
- School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
- Department of Psychiatry, Faculty of Medicine, University of Turku, Turku, Finland.
ORCID-Profile: Antti Mustonen, Heidi Taipale, Venla Ellilä, Marta Di Forti, Solja Niemelä
Zitieren
APA
Mustonen, A., Taipale, H., Denissoff, A., Ellilä, V., Di Forti, M., Tanskanen, A., Mittendorfer-Rutz, E., Tiihonen, J., & Niemelä, S. (2026). Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis. The British Journal of Psychiatry, 228(4), 317-323. https://doi.org/10.1192/bjp.2025.72
Vancouver
Mustonen A, Taipale H, Denissoff A, Ellilä V, Di Forti M, Tanskanen A, et al. Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis. The British Journal of Psychiatry. 2026;228(4):317-323. doi:10.1192/bjp.2025.72
BibTeX
@article{Mustonen2026,
author = {Mustonen, Antti and Taipale, Heidi and Denissoff, Alexander and Ellilä, Venla and Di Forti, Marta and Tanskanen, Antti and Mittendorfer-Rutz, Ellenor and Tiihonen, Jari and Niemelä, Solja},
title = {Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis},
journal = {The British Journal of Psychiatry},
year = {2026},
volume = {228},
number = {4},
pages = {317--323},
doi = {10.1192/bjp.2025.72}
}
EUVIMED